Neuralink Blindsight receives FDA Breakthrough Device Designation for visually impaired patients
Blindsight is a technology meant to bring functional eyesight back to patients who have lost it.
FDA allegedly rejects Musk’s request to test Neuralink chip in humans over safety concerns
The FDA outlined a number of issues that reportedly need addressing before Neuralink can be approved for human testing, including concerns over its lithium battery.